NVCR
NovoCure Limited
NASDAQ · JEHealthcareMedical - Instruments & Supplies
$15.94+0.13%
Price as of Jul 20, 2026
NVCR valuation
NovoCure Limited valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.55x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.58x
- Price / sales
- 2.74x
- Price / cash flow
- -68.67x
Enterprise value
- Enterprise value
- $1.6B
- EV / sales
- 2.43x
- EV / EBITDA
- -10.55x
- EV / EBIT
- -8.94x
- Market cap
- $1.8B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.